Another journalist writes about HIS diagnosis with Stage IV prostate cancer

Scott Monserud is the sports editor for The Denver Post in Denver, CO. In the first of a series of articles entitled “Help, and Hope: A Cancer Journal” he writes about his own personal experience. Click here to get his tale.

ASCO abstracts now available on line

The American Society for Clinical Oncology (ASCO) just released the abstracts for the hundreds of presentations and posters that will be given at the upcoming annual meeting of ASCO in June in Chicago. … READ MORE …

J&J expects to file for approval to market two new prostate cancer drugs

An announcement from Johnson & Johnson yesterday said that the company is projecting filings with regulatory authorities for approval of two new drugs for the treatment of advanced prostate cancer between 2017 and 2021. … READ MORE …

Numbers progressing and time to progression on active surveillance

A new study just published in the World Journal of Urology has provided us with data from the Prostate Cancer Outcomes Registry — Victoria (in Australia) on the progression of men initially managed on active surveillance. … READ MORE …

Genomic profiling of prostate cancer

The “New” Prostate Cancer InfoLink has been made aware of an interesting new initiative under development at The Broad Institute up in Boston. … READ MORE …

More on the new guidelines for treatment of localized prostate cancer

So your sitemaster was able to spend a while this morning reading through the full 56 pages of the new AUA/ASTRO/SUO guidelines on the treatment of localized prostate cancer. … READ MORE …

CureTalk on genomic testing and precision medicine

For interested readers, there will be a CureTalk this evening on precision medicine and the role of genetic/genomic testing in the selection of appropriate forms of treatment. It will not be prostate cancer-specific, but its role in prostate cancer will be addressed. … READ MORE …